SR
Sangita Ranjitsingh Sawant
About Sangita Ranjitsingh Sawant
Data last updated:
Sangita Ranjitsingh Sawant is a Director at Vitts Pharma Private Limited (since 2014). The company operates in Chemicals. Vitts Pharma Private Limited reported revenue of ₹8.9 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vitts Pharma Private Limited U24100MH2014PTC259878 | Director | 01 Dec 2014 | 2014 | ₹8.9 Lakh (FY 2019) | Active |
Board colleagues of Sangita Ranjitsingh Sawant
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditi Kuldeep Patil | 07005331 | Vitts Pharma Private Limited | Director |
| Kuldeep Narayanrao Patil | 07005148 | Vitts Pharma Private Limited | Director |
| Rajendra Sachichidanand Gosavi | 07005153 | Vitts Pharma Private Limited | Director |
| Ranjitsingh Sambhajirao Sawant | 07005159 | Vitts Pharma Private Limited | Director |
| Shetal Rajendra Gosavi | 00287028 | Vitts Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangita Ranjitsingh Sawant
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangita Ranjitsingh Sawant
Sangita Ranjitsingh Sawant currently holds 1 directorship: Vitts Pharma Private Limited (Director, since 01 Dec 2014, revenue ₹8.9 Lakh (FY 2019)).
Sangita Ranjitsingh Sawant was first appointed on 01 Dec 2014 as Director at Vitts Pharma Private Limited.
The current boards of Sangita Ranjitsingh Sawant's companies include Aditi Kuldeep Patil (Vitts Pharma Private Limited), Kuldeep Narayanrao Patil (Vitts Pharma Private Limited), Rajendra Sachichidanand Gosavi (Vitts Pharma Private Limited), Ranjitsingh Sambhajirao Sawant (Vitts Pharma Private Limited), Shetal Rajendra Gosavi (Vitts Pharma Private Limited).